Pediatric Grand Rounds - "Effects of chemotherapy on biomarkers with diagnostic and prognostic value for metabolic syndrome"

Topic: Effects of chemotherapy on biomarkers with diagnostic and prognostic value for metabolic syndrome

Objectives: At the conclusion of this session, the participant should be able to:

1. Recognize defining factors of metabolic syndrome and physiology in the body associated with it.
2. Recognize the increased risk of metabolic syndrome in pediatric leukemia survivors.
3. Discuss morbidity and mortality associated with metabolic syndrome in pediatric leukemia survivors.
4. Learn how molecular biomarkers can be utilized to detect and screen for metabolic syndrome prior to symptom onset.
5. Learn about current research projects that explain effects of chemotherapy on biomarkers and potential utility for future use.

Disclosure: Dr. Wells disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationships to disclose.

Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.

Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please call Tina Smith 904-476-6747 or Miguel Perez 904-248-8490 for any technical assistance.